nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—myenteric nerve plexus—rectum cancer	0.372	0.372	CbGeAlD
Cinitapride—HTR2A—vein—rectum cancer	0.239	0.239	CbGeAlD
Cinitapride—HTR2A—autonomic nervous system—rectum cancer	0.172	0.172	CbGeAlD
Cinitapride—HTR1A—renal system—rectum cancer	0.0576	0.0576	CbGeAlD
Cinitapride—HTR2A—epithelium—rectum cancer	0.037	0.037	CbGeAlD
Cinitapride—HTR2A—smooth muscle tissue—rectum cancer	0.0356	0.0356	CbGeAlD
Cinitapride—HTR2A—renal system—rectum cancer	0.0343	0.0343	CbGeAlD
Cinitapride—HTR2A—female reproductive system—rectum cancer	0.0275	0.0275	CbGeAlD
Cinitapride—HTR2A—vagina—rectum cancer	0.0249	0.0249	CbGeAlD
